In only a few short years, Colorado has grown as a showcase state for the Bioscience industry. We are home to over 470 bioscience companies involved in the development of biotechnology, pharmaceuticals, medical devices, and bio-fuels. The number of Colorado companies has grown by more than fifty percent since 2001, including 150 new companies created since 2004.

Governor Ritter and the State Legislatures leadership in creating a $26.5 million Bioscience Research Grant Program symbolized the commitment by Colorado to promote the industry, help businesses thrive, and enable research institutions to commercialize viable technologies. With great representation coming from the Colorado BioScience Association (CBSA), and the attention of state and local policymakers, Colorado is poised to be leader in solving the worlds health problems.

The bioscience industry in Colorado is fueled in part by our world class research institutions. Colorado University, Colorado State University and National Jewish Medical and Research Center are leaders in research and development; with CUs Anschutz Medical Campus at Fitzsimmons, and their recent announcement of the return of Nobel Prize-winning molecular researcher Tom Cech; the work being done at CSU in Ft. Collins with cancer, infectious diseases and renewable energy super-clusters, and the number one respiratory hospital in the country, National Jewish.

With industry leaders in Colorado like Amgen, Roche and Gambro, smaller entrepreneurial minded start-up companies like Apoplogic and Solix Biofuels, and developments like Forest City’s Science and Technology Park at Fitzsimmons, Colorado is a regional capital of Bioscience that is growing fast.

Colorado BioScience Association (CBSA) shapes policies and develops programs to help Colorado’s bioscience community prosper. We facilitate growth through advocacy, representation and service. CBSA supports the economic development of Colorado through the creation of a premier bioscience cluster within the state.

As the recognized statewide bioindustry trade association, AZBio seeks to unify, empower and advance its member organizations, allowing them to benefit individually by acting collectively. AZBio strives to enhance the environment that makes Arizona a place where bioscience companies can grow and succeed.

AZBio is the state affiliate in Arizona of the Biotechnology Industry Organization (BIO), the preeminent national association for biotechnology companies, and of Advamed, the largest association representing manufacturers of medical devices, diagnostic products and medical information systems.

Since 1991, Capital Advisors Group has been a leading independent institutional investment advisor focused on helping corporate treasurers extend their cash life. We do this in two ways: First, we've spent the past 18 years managing short-term cash investments for our clientele, working to maximize returns, minimize risk and provide customized accounting reports that suit specific client needs. Second, our wholly-owned subsidiary, Debt Advisors Group, aims to help clients determine appropriate debt levels to realize their optimum capital structure. We then work on clients' behalf to source a network of more than 50 lenders for each debt deal and we help negotiate the best available terms based on our knowledge of current market conditions. Independently, these services aim to provide clients a level of quality and experience that cannot be found elsewhere. Together, they can offer your treasury department an end-to-end solution that is entirely unique in the market.

Cooley Godward Kronish is a national law firm for the converging worlds of high technology, high finance and high-stakes litigation. We are counselors, strategists and advocates for the foremost private and public companies across a wide variety of industries and in all major technology fields. Our clients include business organizations, entrepreneurs, venture capitalists, financial institutions, private equity firms, professional services firms and real estate owners and developers. Cooley has approximately 675 attorneys and represents clients in more than 20 industries.

With more than 650 lawyers in 19 locations globally, Dorsey provides an integrated, practice approach to its client's legal and business needs. Many of our attorneys have advanced scientific degrees, and industry experience, which inform everything they do. From patent applications, venture capital financing, and licensing agreements to mergers and acquisitions, litigation and initial public offerings.

Ernst & Young is the global leader in providing assurance, tax, transaction and advisory services to biotechnology, pharmaceutical and medical device companies.  No other firm can match our commitment to our clients and deep knowledge of those industries.

The Fitzsimons Redevelopment Authority (FRA) is a partnership of the City of Aurora and the University of Colorado and is responsible for overseeing the creation of the Fitzsimons Life Science District as a world-class environment for life science companies. The FRA directs the commercial developments in the District, including the Colorado Science +Technology Park at Fitzsimons, along with its partner, Forest City Enterprises. In its oversight role, the FRA is dedicated to providing life science companies an environment where they can thrive and resources to enhance their success.

Forest City Science + Technology Group is recognized as one of the country's leading developers and owners of life science campuses working with the nation's leading universities, corporations and research institutions. Forest City's research parks bring the worlds of technology and real estate together serving as a catalyst through which scientific commercialization can grow and thrive.

The mission of High Country Venture is to invest in the most promising and innovative early stage Colorado companies, help build them into strong, profitable businesses, and to capture that value creation through strategic financial decisions. The Colorado Fund is a venture capital fund seeking to invest in seed and early stage businesses in Colorado. The fund will focus its investments in Life Sciences (including biotechnology, agritechnology, diagnostics and medical devices), information technology (including software and Internet companies) and retail.

At inVentiv Clinical Solutions, we understand the increased regulatory and financial pressures faced by the biopharmaceutical industry today. That’s why we offer comprehensive and flexible services to fit your specific clinical development needs. As a strategic partner, inVentiv Clinical provides clinical trial management and monitoring, data management and biostatistics solutions, medical writing, regulatory consulting and liaison services and patient and investigator recruitment. These services are complimented by traditional clinical staffing capabilities through our industry leading staffing divisions, MedFocus and Smith Hanley Consulting Group. As a division of inVentiv Health, Inc. (NASDAQ: VTIV), we have the unique ability to leverage the expertise of more than 6000 employees from clinical to communications and commercialization to build cutting edge solutions, such as efficient patient recruitment strategies and new technology applications.

Johnson & Johnson Development Corporation (JJDC) is the venture capital subsidiary of Johnson & Johnson. JJDC is comprised of experts and leaders in the health care and technology venture communities who identify early market indicators, health care trends, and strategic investment opportunities. Unlike traditional venture capital firms, JJDC determines the success of an investment’s performance not only in financial returns, but also in the viability of providing strategic growth options for Johnson & Johnson.

Kendall, Koenig & Oelsner is a corporate and business law boutique focusing on transactional legal matters, including mergers and acquisitions, securities, venture capital, credit finance, legal entity formation and commercial contracts. We are committed to providing the highest level of service and expertise with efficiency and creativity. We have worked with clients ranging from start-ups to Fortune 100 companies on deals ranging from the thousands to the billions. With offices in Boulder and Denver, KKO’s dedicated team delivers trusted counsel for all your corporate, commercial, and intellectual property transaction needs.

The Montana Bioscience Alliance serves as a hub for Montana’s biotechnology companies, entrepreneurs, laboratories, hospitals, clinics and universities to commercialize, grow and sustain globally competitive bioscience companies — ultimately to create high-quality jobs and economic opportunity in Montana.

• Exchange information about common issues and opportunities;
• Support initiatives designed to start and grow or attract new biosciences companies;
• Pool resources to pursue joint training, research and development and business development projects that advance the competitiveness of the life sciences cluster;
• Educate the public and students about life science career opportunities;
• Support efforts to build the state’s life sciences research base;
• Extend education, training and business development outreach to the disadvantaged places and people throughout Montana;
• Serve as the interface between the life sciences cluster and state government to help implement and improve the state’s life sciences cluster development strategy.

Morgenthaler Ventures is a leading, national venture capital team with offices in Menlo Park, CA; Boston, MA; and Boulder, CO. It concentrates its investments in life sciences and information technology. Morgenthaler’s Life Science Team focuses on biotechnology and medical devices. The firm has approximately $3 billion under management and has funded more than 300 companies over its 40-year history.

From biotech and pharmaceuticals to medical devices and biofuels. human health, veterinary medicine and plant science. Across the state, Oklahoma's bioscience sector is vibrant, diverse and growing. The Oklahoma Bioscience Association, OKBio, is at the center of it all - the focal point for Oklahoma's emerging bioscience cluster. Launched in 2008, OKBio is a statewide membership organization exclusively dedicated to the growth of Oklahoma's bioscience sector. OKBio is the new voice of the Oklahoma bioscience community.

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA works to conduct effective advocacy for public policies that encourage discovery of important new medicines for patients.

RedScript Ventures™ is the business incubator for emergent business opportunities of interest to Johnson & Johnson Corporate Development. Through a "virtual" environment, RedScript™ employs a multi-stage approach to business development – from technical validation through to technology and product development, and ultimately commercialization - with the goal of launching significant new businesses into the Johnson & Johnson family of companies.

The Rocky Mountain Venture Capital Association represents the interests of venture capitalists and venture capital-backed companies in our region. It is the mission of the RMVCA to be a leading venture capital association with the strategic intent of making our region one of the top markets for venture activity. There are more than 180 venture capital professionals from 43 firms actively engaged in investing in the region. These firms represent more than $6.3billion in capital in aggregate.

Sequel Venture Partners, based in Boulder, Colorado, provides venture funding for early stage technology businesses. Sequel manages $400 million in capital, and specializes in Healthcare, Internet and Enterprise IT, Clean Technology and Internet based services.

Silicon Valley Bank is the premier commercial bank for companies in the technology, life science, venture capital/private equity and premium wine industries. SVB provides a comprehensive suite of financing solutions, treasury management, corporate investment and international banking services to its clients worldwide. Through its focus on specialized markets and extensive knowledge of the people and business issues driving them, Silicon Valley Bank provides a level of service and partnership that measurably impacts its clients’ success. Founded in 1983 and headquartered in Santa Clara, Calif., the company serves clients around the world through 27 U.S. offices and international operations in China, India, Israel and the United Kingdom. Silicon Valley Bank is a member of global financial services firm SVB Financial Group (Nasdaq: SIVB), with SVB Analytics, SVB Capital, SVB Global and SVB Private Client Services. More information on the company can be found at www.svb.com.
Silicon Valley Bank is the California bank subsidiary and the commercial banking operation of SVB Financial Group. Banking services are provided by Silicon Valley Bank, a member of the FDIC and the Federal Reserve System. SVB Private Client Services is a division of Silicon Valley Bank. SVB Financial Group is also a member of the Federal Reserve System.

Thousands of organizations have turned to TriNet for human resources, benefits, payroll, workers compensation, and strategic human capital services. As their trusted HR advisor, TriNet helps these companies contain HR costs, minimize employer-related risk, and relieve the administrative burden of HR.
TriNet also offers a set of Strategic Advisory Services that match companies at every point in their lifecycle, including such offerings as Talent Acquisition, Performance Management, and Training/Development. All of TriNet’s services are supported by a network of dedicated human capital consultants and experts, and enabled by best-in-class HR technology from PeopleSoft/Oracle.

Ubiquity is a strategy and creative services company specializing in medical technology and healthcare launches. We help companies build marketing programs, with strategic clarity, to better define market positioning and branding that permeates through product development, launch and product revisions.

Utah is home to over 4,300 life science and information technology companies. These industries provide roughly 63,000 high-paying, high-quality jobs in the state and generate an estimated $3.4 billion in annual wages.1 According to the Utah Department of Workforce Services, in 2006, the Utah life science industry accounted for roughly 26,800 jobs in the state with an average monthly salary of $4,213 – 29% higher than the average monthly nonfarm employment salary in the state.

vSpring Capital is an early-stage venture capital firm with $394 million under management. With offices in Utah and New Mexico, vSpring invests in information technology and life science companies that have the potential to transform their markets and create lasting value.